Thalidomide for control delayed vomiting in cancer patients receiving chemotherapy
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2016; 26 (11): 900-903
em Inglês
| IMEMR
| ID: emr-183339
ABSTRACT
Objective:
To explore the efficacy and safety of thalidomide for the treatment of delayed vomiting, induced by chemotherapy in cancer patients
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Coll. Physicians Surg. Pak.
Ano de publicação:
2016
Similares
MEDLINE
...
LILACS
LIS